REVENIR

Serial Number 79370662
Registration 7616651
700

Registration Progress

Application Filed
Mar 15, 2023
Under Examination
Approved for Publication
Nov 5, 2024
Published for Opposition
Nov 5, 2024
Registered
Dec 24, 2024

Trademark Image

REVENIR

Basic Information

Serial Number
79370662
Registration Number
7616651
Filing Date
March 15, 2023
Registration Date
December 24, 2024
Published for Opposition
November 5, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Dec 24, 2024
Registration
Registered
Classes
042

Rights Holder

Congruence Therapeutics Inc.

99
Address
7171 Rue Frederick-Banting
Suite 117 Saint-Laurent QC H4S 1Z9
CA

Ownership History

Congruence Therapeutics Inc.

Original Applicant
99
CA

Congruence Therapeutics Inc.

Owner at Publication
99
CA

Congruence Therapeutics Inc.

Original Registrant
99
CA

Legal Representation

Attorney
Kelsey A. Cloud

USPTO Deadlines

Next Deadline
1972 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-12-24)
Due Date
December 24, 2030
Grace Period Ends
June 24, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

32 events
Date Code Type Description Documents
Jun 27, 2025 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Jun 11, 2025 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Jun 10, 2025 FIMP P FINAL DISPOSITION PROCESSED Loading...
Mar 24, 2025 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Dec 24, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Dec 24, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Nov 9, 2024 OPNX P NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Loading...
Nov 5, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 5, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 23, 2024 OPNR P NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Loading...
Oct 23, 2024 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Oct 18, 2024 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Oct 16, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 25, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 24, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 23, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 23, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 30, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jul 30, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jul 30, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jul 8, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 8, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jul 8, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 31, 2024 RFNT P REFUSAL PROCESSED BY IB Loading...
Jan 8, 2024 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Jan 8, 2024 RFRR P REFUSAL PROCESSED BY MPU Loading...
Dec 23, 2023 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Dec 22, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Dec 12, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
May 30, 2023 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
May 26, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 25, 2023 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 042
Platform as a service (PaaS) featuring computer software platforms for computational drug discovery

Additional Information

Translation
The English translation of "REVENIR" in the mark is "to revert".

Classification

International Classes
042